A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications (Q48178985)

9 February 2018

http://europepmc.org/abstract/MED/29205637

field guide

0 references

review article

1 reference

title

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications (English)

1 reference

9 February 2018

http://europepmc.org/abstract/MED/29205637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Anja Riediger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Thoas Fioretos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Peter Schirmacher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Volker Endris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Steffen Dietz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

5 December 2017

1 reference

9 February 2018

http://europepmc.org/abstract/MED/29205637

published in

Genes, Chromosomes and Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

123-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

Neoplastic characteristics of the DNA found in the plasma of cancer patients

11 June 2020

cites work

1 reference

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.

21 January 2018

1 reference

Liquid biopsies for bladder cancer

21 January 2018

1 reference

Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer

21 January 2018

1 reference

Detection of a K-ras mutation in urine of patients with colorectal cancer

21 January 2018

1 reference

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

21 January 2018

1 reference

Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series.

21 January 2018

1 reference

Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients

21 January 2018

1 reference

21 January 2018

1 reference

Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study

21 January 2018

1 reference

Brain tumor mutations detected in cerebral spinal fluid

21 January 2018

1 reference

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib

21 January 2018

1 reference

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

21 January 2018

1 reference

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

21 January 2018

1 reference

Metabolic DNA as the origin of spontaneously released DNA?

21 January 2018

1 reference

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer

21 January 2018

1 reference

Double-stranded DNA in exosomes: a novel biomarker in cancer detection

21 January 2018

1 reference

Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood

21 January 2018

1 reference

Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus

21 January 2018

1 reference

High fragmentation characterizes tumour-derived circulating DNA.

21 January 2018

1 reference

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

21 January 2018

1 reference

Fragment Length of Circulating Tumor DNA

21 January 2018

1 reference

Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin

21 January 2018

1 reference

Presence of fetal DNA in maternal plasma and serum

21 January 2018

1 reference

Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury

21 January 2018

1 reference

The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum

21 January 2018

1 reference

Elevated cell-free serum DNA detected in patients with myocardial infarction

21 January 2018

1 reference

Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders

21 January 2018

1 reference

Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke.

21 January 2018

1 reference

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

21 January 2018

1 reference

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

21 January 2018

1 reference

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

21 January 2018

1 reference

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

21 January 2018

1 reference

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

21 January 2018

1 reference

Tracking the Evolution of Non-Small-Cell Lung Cancer

21 January 2018

1 reference

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

21 January 2018

1 reference

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

21 January 2018

1 reference

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

21 January 2018

1 reference

Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas

21 January 2018

1 reference

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

21 January 2018

1 reference

Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer.

21 January 2018

1 reference

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer

21 January 2018

1 reference

Integrated digital error suppression for improved detection of circulating tumor DNA

21 January 2018

1 reference

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

21 January 2018

1 reference

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

21 January 2018

1 reference

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

21 January 2018

1 reference

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer

21 January 2018

1 reference

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

21 January 2018

1 reference

Influence of plasma processing on recovery and analysis of circulating nucleic acids

21 January 2018

1 reference

Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid

21 January 2018

1 reference

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.

21 January 2018

1 reference

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample.

21 January 2018

1 reference

Circulating cell free DNA: Preanalytical considerations

21 January 2018

1 reference

The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.

21 January 2018

1 reference

Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)

21 January 2018

1 reference

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes.

21 January 2018

1 reference

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing

21 January 2018

1 reference

A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device

21 January 2018

1 reference

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing

21 January 2018

1 reference

Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.

21 January 2018

1 reference

EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial.

21 January 2018

1 reference

Use of magnetic beads for plasma cell-free DNA extraction: toward automation of plasma DNA analysis for molecular diagnostics.

21 January 2018

1 reference

Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing

21 January 2018

1 reference

A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

21 January 2018

1 reference

Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan.

21 January 2018

1 reference

Purification of Circulating Cell-Free DNA from Plasma and Urine Using the Automated Large-Volume Extraction on the QIAsymphony® SP Instrument

21 January 2018

1 reference

Liquid biopsies come of age: towards implementation of circulating tumour DNA.

21 January 2018

1 reference

Direct quantification of cell-free, circulating DNA from unpurified plasma

21 January 2018

1 reference

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma

21 January 2018

1 reference

Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.

21 January 2018

1 reference

Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification

21 January 2018

1 reference

Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.

21 January 2018

1 reference

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

21 January 2018

1 reference

Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA

21 January 2018

1 reference

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients

21 January 2018

1 reference

Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues

21 January 2018

1 reference

Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

21 January 2018

1 reference

Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors

21 January 2018

1 reference

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

21 January 2018

1 reference

Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?

21 January 2018

1 reference

Direct detection of early-stage cancers using circulating tumor DNA.

21 January 2018

1 reference

Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

21 January 2018

1 reference

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

21 January 2018

1 reference

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

21 January 2018

1 reference

Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing

21 January 2018

1 reference

Liquid biopsies: genotyping circulating tumor DNA

21 January 2018

1 reference

Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer

21 January 2018

1 reference

EGFR T790M mutation testing within the osimertinib AURA Phase I study

21 January 2018

1 reference

ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study

21 January 2018

1 reference

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

21 January 2018

1 reference

Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection

21 January 2018

1 reference

Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma

21 January 2018

1 reference

PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients

21 January 2018

1 reference

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.

21 January 2018

1 reference

Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances

21 January 2018

1 reference

Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients

21 January 2018

1 reference

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

21 January 2018

1 reference

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

21 January 2018

1 reference

BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions

21 January 2018

1 reference

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

21 January 2018

1 reference

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

21 January 2018

1 reference

Comprehensive Analysis of the Discordance of EGFR Mutation Status between Tumor Tissues and Matched Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer.

21 January 2018

1 reference

Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.

21 January 2018

1 reference

Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer

21 January 2018

1 reference

Highly precise measurement of HIV DNA by droplet digital PCR.

21 January 2018

1 reference

Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients

21 January 2018

1 reference

Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data

21 January 2018

1 reference

Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine

21 January 2018

1 reference

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.

21 January 2018

1 reference

Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients

21 January 2018

1 reference

Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.

21 January 2018

1 reference

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

Detection and quantification of rare mutations with massively parallel sequencing

21 January 2018

1 reference

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

21 January 2018

1 reference

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

21 January 2018

1 reference

Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.

21 January 2018

1 reference

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

21 January 2018

1 reference

Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease

21 January 2018

1 reference

Evaluation of exome sequencing to estimate tumor burden in plasma

21 January 2018

1 reference

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing

21 January 2018

1 reference

Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.

21 January 2018

1 reference

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.

21 January 2018

1 reference

Assessment of circulating copy number variant detection for cancer screening

21 January 2018

1 reference

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

21 January 2018

1 reference

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

21 January 2018

1 reference

The landscape of metastatic progression patterns across major human cancers

21 January 2018

1 reference

Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis

21 January 2018

1 reference

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

21 January 2018

1 reference

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

21 January 2018

1 reference

TP53andKRAS2Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

21 January 2018

1 reference

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

Multitarget stool DNA testing for colorectal-cancer screening

21 January 2018

1 reference

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

21 January 2018

1 reference

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

21 January 2018

1 reference

21 January 2018

1 reference

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

21 January 2018

1 reference

21 January 2018

1 reference

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

21 January 2018

1 reference

Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway

21 January 2018

1 reference

Shouldn't we care about the biology of benign tumours?

21 January 2018

1 reference

Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma

21 January 2018

1 reference

Signatures of mutational processes in human cancer

21 January 2018

1 reference

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

21 January 2018

1 reference

Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

21 January 2018

1 reference

Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRA.

21 January 2018

1 reference

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

21 January 2018

1 reference

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

21 January 2018

1 reference

Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.

21 January 2018

1 reference

EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

21 January 2018

1 reference

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

21 January 2018

1 reference

Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA.

21 January 2018

1 reference

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

21 January 2018

1 reference

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

21 January 2018

1 reference

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

21 January 2018

1 reference

Cell-free circulating tumour DNA as a liquid biopsy in breast cancer

21 January 2018

1 reference

What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?

21 January 2018

1 reference

Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA.

21 January 2018

1 reference

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.

21 January 2018

1 reference

Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma

21 January 2018

1 reference

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

21 January 2018

1 reference

Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib

21 January 2018

1 reference

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer

21 January 2018

1 reference

Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic).

21 January 2018

1 reference

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

21 January 2018

1 reference

Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy

21 January 2018

1 reference

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.

21 January 2018

1 reference

Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report

21 January 2018

1 reference

Integrating liquid biopsies into the management of cancer

21 January 2018

1 reference

Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer

21 January 2018

1 reference

The origin and mechanism of circulating DNA

21 January 2018

1 reference

7 January 2021

Non-blood circulating tumor DNA detection in cancer

1 reference

7 January 2021

Increased concentrations of cell-free plasma DNA after exhaustive exercise

1 reference

7 January 2021

The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke

1 reference

7 January 2021

The importance of careful blood processing in isolation of cell-free DNA

1 reference

7 January 2021

Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience

1 reference

7 January 2021

Changes in Concentration of DNA in Serum and Plasma during Storage of Blood Samples

1 reference

7 January 2021

Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise

1 reference

7 January 2021

Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer

1 reference

7 January 2021

Diagnostic accuracy and safety of fine-needle aspiration biopsy of the parapharyngeal space

1 reference

7 January 2021

Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.

1 reference

7 January 2021

Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens

1 reference

7 January 2021

Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing

1 reference

7 January 2021

High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.22517

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205637%20AND%20SRC:MED&resulttype=core&format=json